Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchGinkgo Bioworks launches ADME-One™, a high-throughput ADME platform for drug discovery co-developed with Tangible Scientific and Inductive Bio.
May 26, 2026
BostonOtherManufacturingBiotechnologySustainabilitySoftwareScience And Engineering
Product Description
The new platform, ADME-One™, integrates a Tier 1 ADME panel with AI-driven pharmacokinetic projections, enabling earlier decision-making in drug discovery processes.
Company Information
Company
Ginkgo Bioworks
Location
Boston, Massachusetts, United States
About
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ginkgo Bioworks ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.